Valuation (19%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -1.56 | -23.37 |
PEG Ratio (TTM) | 0.14 | -7.10 |
P/S Ratio (TTM) | 21.29 | 44.34 |
P/B Ratio (TTM) | -2.83 | 33.03 |
P/FCF Ratio (TTM) | -2.26 | -7.73 |
Price to 5YR AVG Earnings Ratio | -1.57 | -7.08 |
Price to 5YR AVG FCF Ratio | -4.92 | -13.02 |
Profitability (50%) |
Company | Industry |
---|---|---|
ROA (TTM) | -87.70% | -15.67% |
ROE (TTM) | 211.43% | 27.44% |
Net Profit Margin (TTM) | -1,292.14% | -627.99% |
ROIC 5YR AVG | 140.09% | -4.84% |
Growth (8%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -19.88% | -1,833.46% | -1,102.36% |
Revenue | 146.67% | N/A | N/A |
Net Income | -23.02% | -5,386.37% | -3,240.02% |
Cash Flow | -21.80% | -1,224.35% | -733.11% |
Health (28%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 5.73 | 5.66 |
Quick Ratio (TTM) | 5.68 | 5.44 |
D/E Ratio (TTM) | -0.94 | 1.19 |
Interest Coverage (TTM) | -4.33 | -5.92 |
Piotroski F-Score | 4 | 5 |
Altman Z-Score | N/A | 13.21 |
LTL to 5YR AVG FCF | -1.22 | 0.09 |
Shares Outstanding Growth 5YR AVG | 54.17% | 39.51% |